Clearside Biomedical Inc. (CLSD)
Market Open
12 Mar, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 41
0
0%
$
2.15M Market Cap
- P/E Ratio
- Div Yield
2.05M Volume
-0.53 Eps
$ 0.41
Previous Close Want to track CLSD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clearside Biomedical Inc. (CLSD) Statistics
Valuation metrics
Market Cap 2.15M
Enterprise value -4.21M
Trailing P/E (ttm) -0.11
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.71
Price/Book (mrq) -0.04
Enterprise Value/Revenue -1.39
Enterprise Value/EBITDA 0.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.22K
Average volume (90 days) 48.67K
Price summary
52-Week low 0.31
52-Week high 17.1
Beta -
50-Day moving average 0.19
200-Day moving average 0.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 15 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.18%
Operating margin -5.23%
Operational effectiveness
Return on assets -1.61%
Return on equity 0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.3
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 2.98%
Book value per share (mrq) -10.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
